Tregs, as one of the most important parts of immunosuppressive cells, can inhibit tumor-specific immune responses with the co-inhibitory molecules such as CTLA-4, TIGIT, LAG3, and CD28, and promote immune evasion, thus facilitating tumor cell proliferation [59–61]. This evidence concerns the gene CTLA4 and neoplasm.